NASDAQ:PBYI
Puma Biotechnology, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.pumabiotechnology.comipo date
Apr 24, 2012
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combinat...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus